Header Logo

Connection

ALAN SWANN to Middle Aged

Back to Details
This is a "connection" page, showing publications ALAN SWANN has written about Middle Aged.
ALAN SWANN
Connection Strength
0.630
Middle Aged
  1. Lurasidone for major depressive disorder with mixed features and irritability: a post-hoc analysis. CNS Spectr. 2017 Apr; 22(2):228-235.
    View in: PubMed
    Score: 0.031
  2. Heightened early-attentional stimulus orienting and impulsive action in men with antisocial personality disorder. Eur Arch Psychiatry Clin Neurosci. 2017 Oct; 267(7):697-707.
    View in: PubMed
    Score: 0.030
  3. Trait impulsivity and increased pre-attentional sensitivity to intense stimuli in bipolar disorder and controls. J Psychiatr Res. 2015 Jan; 60:73-80.
    View in: PubMed
    Score: 0.026
  4. Pre-attentive information processing and impulsivity in bipolar disorder. J Psychiatr Res. 2013 Dec; 47(12):1917-24.
    View in: PubMed
    Score: 0.024
  5. Norepinephrine and impulsivity: effects of acute yohimbine. Psychopharmacology (Berl). 2013 Sep; 229(1):83-94.
    View in: PubMed
    Score: 0.024
  6. Multivariate analysis of bipolar mania: retrospectively assessed structure of bipolar I manic and mixed episodes in randomized clinical trial participants. J Affect Disord. 2013 Jan 10; 144(1-2):59-64.
    View in: PubMed
    Score: 0.022
  7. Antisocial personality disorder and borderline symptoms are differentially related to impulsivity and course of illness in bipolar disorder. J Affect Disord. 2013 Jun; 148(2-3):384-90.
    View in: PubMed
    Score: 0.022
  8. Differential relationships of impulsivity or antisocial symptoms on P50, N100, or?P200 auditory sensory gating in controls and antisocial personality disorder. J Psychiatr Res. 2012 Jun; 46(6):743-50.
    View in: PubMed
    Score: 0.022
  9. Interacting mechanisms of impulsivity in bipolar disorder and antisocial personality disorder. J Psychiatr Res. 2011 Nov; 45(11):1477-82.
    View in: PubMed
    Score: 0.021
  10. Pharmacologic mood destabilization: case vignettes. CNS Spectr. 2009 Nov; 14(11 Suppl 11):9-11; discussion 12-4.
    View in: PubMed
    Score: 0.019
  11. Increased trait-like impulsivity and course of illness in bipolar disorder. Bipolar Disord. 2009 May; 11(3):280-8.
    View in: PubMed
    Score: 0.018
  12. Trait impulsivity and response inhibition in antisocial personality disorder. J Psychiatr Res. 2009 Aug; 43(12):1057-63.
    View in: PubMed
    Score: 0.018
  13. High-order brain interactions during ketamine-induced state changes: A functional marker of response in late-life treatment-resistant depression? Transl Psychiatry. 2026 Jul 04; 16(1).
    View in: PubMed
    Score: 0.015
  14. The association between cannabis use and suicidal intensity in psychiatric inpatients. Am J Addict. 2025 Sep; 34(5):506-516.
    View in: PubMed
    Score: 0.014
  15. Effects of the KCNQ (Kv7) Channel Opener Ezogabine on Resting-State Functional Connectivity of Striatal Brain Reward Regions, Depression, and Anhedonia in Major Depressive Disorder: Results From a Randomized Controlled Trial. Biol Psychiatry. 2025 Oct 01; 98(7):568-577.
    View in: PubMed
    Score: 0.013
  16. Correlates of suicidal behaviors and genetic risk among United States veterans with schizophrenia or bipolar I disorder. Mol Psychiatry. 2024 08; 29(8):2399-2407.
    View in: PubMed
    Score: 0.013
  17. Differentiating anxiety and depression in older adults with generalized anxiety disorder. Psychol Assess. 2003 Jun; 15(2):184-92.
    View in: PubMed
    Score: 0.012
  18. Familial transmission of Continuous Performance Test behavior: attentional and impulsive response characteristics. J Gen Psychol. 2003 Jan; 130(1):5-21.
    View in: PubMed
    Score: 0.012
  19. Two models of impulsivity: relationship to personality traits and psychopathology. Biol Psychiatry. 2002 Jun 15; 51(12):988-94.
    View in: PubMed
    Score: 0.011
  20. Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of illness in randomized clinical trial participants. J Affect Disord. 2001 Dec; 67(1-3):123-32.
    View in: PubMed
    Score: 0.011
  21. Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial. Neuropsychopharmacology. 2022 04; 47(5):1088-1095.
    View in: PubMed
    Score: 0.011
  22. Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial. Am J Psychiatry. 2021 05 01; 178(5):437-446.
    View in: PubMed
    Score: 0.010
  23. ECT in mixed affective states: a case series. J ECT. 2000 Jun; 16(2):183-8.
    View in: PubMed
    Score: 0.010
  24. Generalized anxiety disorder in older adults: examining the relation between clinician severity ratings and patient self-report measures. Depress Anxiety. 2000; 12(4):217-25.
    View in: PubMed
    Score: 0.009
  25. Mania: gender, transmitter function, and response to treatment. Psychiatry Res. 1999 Oct 18; 88(1):55-61.
    View in: PubMed
    Score: 0.009
  26. Psychomotor performance and monoamine function in bipolar and unipolar affective disorders. Biol Psychiatry. 1999 Apr 15; 45(8):979-88.
    View in: PubMed
    Score: 0.009
  27. Droperidol in the interim management of severe mania: case reports and literature review. Clin Neuropharmacol. 1998 Sep-Oct; 21(5):316-8.
    View in: PubMed
    Score: 0.009
  28. Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response. J Clin Psychopharmacol. 1997 Apr; 17(2):78-83.
    View in: PubMed
    Score: 0.008
  29. Psychometric properties of the MSPSS and NOS in psychiatric outpatients. J Clin Psychol. 1995 Sep; 51(5):593-602.
    View in: PubMed
    Score: 0.007
  30. Mixed mania: apparent induction by a tricyclic antidepressant in five consecutively treated patients with bipolar depression. Biol Psychiatry. 1995 Jan 01; 37(1):60-2.
    View in: PubMed
    Score: 0.007
  31. Depressive mania versus agitated depression: biogenic amine and hypothalamic-pituitary-adrenocortical function. Biol Psychiatry. 1994 May 15; 35(10):803-13.
    View in: PubMed
    Score: 0.006
  32. Depressive mania: response of residual depression to bupropion. Biol Psychiatry. 1994 Apr 01; 35(7):493-4.
    View in: PubMed
    Score: 0.006
  33. Is impulsivity a common trait in bipolar and unipolar disorders? Bipolar Disord. 2013 Mar; 15(2):223-7.
    View in: PubMed
    Score: 0.006
  34. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania. Acta Psychiatr Scand. 1992 Apr; 85(4):270-4.
    View in: PubMed
    Score: 0.005
  35. Different measures of impulsivity in patients with anxiety disorders: a case control study. Psychiatry Res. 2012 May 30; 197(3):231-6.
    View in: PubMed
    Score: 0.005
  36. Does anxiety increase impulsivity in patients with bipolar disorder or major depressive disorder? J Psychiatr Res. 2012 May; 46(5):616-21.
    View in: PubMed
    Score: 0.005
  37. Mania: sympathoadrenal function and clinical state. Psychiatry Res. 1991 May; 37(2):195-205.
    View in: PubMed
    Score: 0.005
  38. Relationship between impulsivity and decision making in cocaine dependence. Psychiatry Res. 2010 Jul 30; 178(2):299-304.
    View in: PubMed
    Score: 0.005
  39. Stress, depression, and mania: relationship between perceived role of stressful events and clinical and biochemical characteristics. Acta Psychiatr Scand. 1990 Apr; 81(4):389-97.
    View in: PubMed
    Score: 0.005
  40. Lithium distribution in mania: single-dose pharmacokinetics and sympathoadrenal function. Psychiatry Res. 1990 Apr; 32(1):71-84.
    View in: PubMed
    Score: 0.005
  41. A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. Alcohol Clin Exp Res. 2009 Nov; 33(11):1863-9.
    View in: PubMed
    Score: 0.005
  42. Low MHPG and continuing treatment in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry. 1989; 13(5):701-7.
    View in: PubMed
    Score: 0.004
  43. Long-term outpatient treatment of senile dementia with oral physostigmine. J Clin Psychiatry. 1988 Oct; 49(10):400-4.
    View in: PubMed
    Score: 0.004
  44. The economic and social costs of panic disorder. Hosp Community Psychiatry. 1987 Dec; 38(12):1277-9, 1288.
    View in: PubMed
    Score: 0.004
  45. Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome. Arch Gen Psychiatry. 1987 Apr; 44(4):345-54.
    View in: PubMed
    Score: 0.004
  46. Lithium distribution in mania: plasma and red blood cell lithium, clinical state, and monoamine metabolites during lithium treatment. Psychiatry Res. 1987 Jan; 20(1):1-12.
    View in: PubMed
    Score: 0.004
  47. Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial. Am J Drug Alcohol Abuse. 2007; 33(3):367-78.
    View in: PubMed
    Score: 0.004
  48. A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. J Clin Psychiatry. 2006 Oct; 67(10):1501-10.
    View in: PubMed
    Score: 0.004
  49. Lithium treatment of mania: clinical characteristics, specificity of symptom change, and outcome. Psychiatry Res. 1986 Jun; 18(2):127-41.
    View in: PubMed
    Score: 0.004
  50. Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials. CNS Drugs. 2006; 20(3):219-31.
    View in: PubMed
    Score: 0.004
  51. Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo. Neuropsychopharmacology. 2005 Oct; 30(10):1932-9.
    View in: PubMed
    Score: 0.003
  52. Reduced anterior corpus callosum white matter integrity is related to increased impulsivity and reduced discriminability in cocaine-dependent subjects: diffusion tensor imaging. Neuropsychopharmacology. 2005 Mar; 30(3):610-7.
    View in: PubMed
    Score: 0.003
  53. Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial. BMJ. 2005 Apr 16; 330(7496):874.
    View in: PubMed
    Score: 0.003
  54. Self-inflicted gunshot wounds: lethality of method versus intent. Am J Psychiatry. 1985 Feb; 142(2):228-31.
    View in: PubMed
    Score: 0.003
  55. Efficacy of oral physostigmine in primary degenerative dementia. A double-blind study of response to different dose level. Psychopharmacology (Berl). 1985; 87(2):147-51.
    View in: PubMed
    Score: 0.003
  56. Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings. Curr Med Res Opin. 2004 Dec; 20(12):1883-93.
    View in: PubMed
    Score: 0.003
  57. A multivantaged behavioural method for measuring onset and sequence of the clinical actions of antidepressants. Int J Neuropsychopharmacol. 2004 Dec; 7(4):471-9.
    View in: PubMed
    Score: 0.003
  58. Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacology. 2003 Jul; 28(7):1374-82.
    View in: PubMed
    Score: 0.003
  59. Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology. 2003 Jun; 28(6):1186-97.
    View in: PubMed
    Score: 0.003
  60. CSF monoamine metabolites in mania. Am J Psychiatry. 1983 Apr; 140(4):396-400.
    View in: PubMed
    Score: 0.003
  61. Cognitive-behavioral treatment of late-life generalized anxiety disorder. J Consult Clin Psychol. 2003 Apr; 71(2):309-19.
    View in: PubMed
    Score: 0.003
  62. A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry. 2002 Dec; 63(12):1148-55.
    View in: PubMed
    Score: 0.003
  63. Serotonin 2a receptor T102C polymorphism and impaired impulse control. Am J Med Genet. 2002 Apr 08; 114(3):336-9.
    View in: PubMed
    Score: 0.003
  64. Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder. J Clin Psychiatry. 2001 Jun; 62(6):439-47.
    View in: PubMed
    Score: 0.003
  65. Integration of suicide prevention into outpatient management of bipolar disorder. J Clin Psychiatry. 2001; 62 Suppl 25:3-11.
    View in: PubMed
    Score: 0.003
  66. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry. 2000 Nov; 61(11):841-50.
    View in: PubMed
    Score: 0.002
  67. Stability of diagnosis in bipolar disorder. J Nerv Ment Dis. 1998 Jan; 186(1):17-23.
    View in: PubMed
    Score: 0.002
  68. Fluvoxamine treatment of trichotillomania. J Clin Psychopharmacol. 1997 Aug; 17(4):278-83.
    View in: PubMed
    Score: 0.002
  69. Effect size of efficacy measures comparing divalproex, lithium and placebo in acute mania. Depress Anxiety. 1997; 6(1):26-30.
    View in: PubMed
    Score: 0.002
  70. Stability of diagnosis in schizophrenia. Am J Psychiatry. 1996 May; 153(5):682-6.
    View in: PubMed
    Score: 0.002
  71. Illness characteristics of patients in clinical drug studies of mania. Psychopharmacol Bull. 1995; 31(1):103-9.
    View in: PubMed
    Score: 0.002
  72. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA. 1994 Mar 23-30; 271(12):918-24.
    View in: PubMed
    Score: 0.002
  73. Expressive characteristics of anxiety in depressed men and women. J Affect Disord. 1993 Aug; 28(4):267-77.
    View in: PubMed
    Score: 0.002
  74. Compliance with clinic attendance by outpatients with schizophrenia. Hosp Community Psychiatry. 1993 Aug; 44(8):764-7.
    View in: PubMed
    Score: 0.002
  75. Treatment of trichotillomania with fluoxetine. J Clin Psychiatry. 1991 Jun; 52(6):282.
    View in: PubMed
    Score: 0.001
  76. Sociodemographic and prior clinical course characteristics associated with treatment response in depressed patients. J Psychiatr Res. 1988; 22(3):227-37.
    View in: PubMed
    Score: 0.001
  77. Plasma MHPG in untreated panic disorder. Biol Psychiatry. 1987 Dec; 22(12):1491-5.
    View in: PubMed
    Score: 0.001
  78. Patients with panic attacks and abnormal EEG results. Am J Psychiatry. 1987 Apr; 144(4):508-9.
    View in: PubMed
    Score: 0.001
  79. Weight loss, cortisol levels, and dexamethasone suppression in major depressive disorder. Acta Psychiatr Scand. 1987 Mar; 75(3):243-50.
    View in: PubMed
    Score: 0.001
  80. Diagnosis and treatment of mixed mania. Am J Psychiatry. 1987 Jan; 144(1):96-8.
    View in: PubMed
    Score: 0.001
  81. Mania. Diagnosis, state measurement and prediction of treatment response. J Affect Disord. 1985 Mar-Apr; 8(2):113-21.
    View in: PubMed
    Score: 0.001
  82. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study. Arch Gen Psychiatry. 1984 Mar; 41(3):257-67.
    View in: PubMed
    Score: 0.001
  83. Plasma and erythrocyte electrolytes in affective disorders. J Affect Disord. 1983 May; 5(2):103-13.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.